Raimón Sanmartí

8.6k total citations
263 papers, 5.3k citations indexed

About

Raimón Sanmartí is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Raimón Sanmartí has authored 263 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Rheumatology, 74 papers in Hematology and 59 papers in Immunology. Recurrent topics in Raimón Sanmartí's work include Rheumatoid Arthritis Research and Therapies (179 papers), Systemic Lupus Erythematosus Research (72 papers) and Autoimmune and Inflammatory Disorders Research (69 papers). Raimón Sanmartí is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (179 papers), Systemic Lupus Erythematosus Research (72 papers) and Autoimmune and Inflammatory Disorders Research (69 papers). Raimón Sanmartí collaborates with scholars based in Spain, United States and United Kingdom. Raimón Sanmartí's co-authors include Juan D. Cañete, M.V. Hernández, Virginia Ruíz-Esquide, Jordi Gratacós, Raquel Celis, Julio Ramírez, Alejandro Balsa, José A. Gómez‐Puerta, Isidoro González‐Álvaro and José L. Pablos and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Raimón Sanmartí

249 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raimón Sanmartí Spain 40 3.6k 1.6k 1.3k 771 455 263 5.3k
Xavier Le Loët France 42 3.3k 0.9× 1.4k 0.9× 1.3k 1.0× 696 0.9× 685 1.5× 198 5.4k
Juan D. Cañete Spain 45 3.8k 1.1× 2.7k 1.7× 1.5k 1.2× 1.1k 1.5× 372 0.8× 218 6.0k
Mahboob U. Rahman United States 38 3.8k 1.0× 1.4k 0.9× 1.6k 1.3× 617 0.8× 428 0.9× 85 5.8k
Mary Chester Wasko United States 33 3.4k 0.9× 976 0.6× 1.2k 1.0× 562 0.7× 315 0.7× 64 5.0k
Jon T. Giles United States 45 3.6k 1.0× 1.5k 0.9× 917 0.7× 877 1.1× 562 1.2× 154 6.6k
Alejandro Balsa Spain 43 3.3k 0.9× 2.4k 1.5× 920 0.7× 962 1.2× 783 1.7× 285 6.1k
E. Martín‐Mola Spain 44 4.2k 1.2× 1.6k 1.0× 1.5k 1.2× 409 0.5× 459 1.0× 113 6.0k
FC Breedveld Netherlands 40 4.1k 1.1× 1.3k 0.8× 1.4k 1.1× 755 1.0× 736 1.6× 102 6.2k
Elisa Gremese Italy 35 2.2k 0.6× 1.2k 0.8× 718 0.6× 700 0.9× 311 0.7× 243 4.2k
Thasia Woodworth United States 37 4.2k 1.1× 2.3k 1.5× 1.5k 1.2× 768 1.0× 602 1.3× 84 7.4k

Countries citing papers authored by Raimón Sanmartí

Since Specialization
Citations

This map shows the geographic impact of Raimón Sanmartí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raimón Sanmartí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raimón Sanmartí more than expected).

Fields of papers citing papers by Raimón Sanmartí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raimón Sanmartí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raimón Sanmartí. The network helps show where Raimón Sanmartí may publish in the future.

Co-authorship network of co-authors of Raimón Sanmartí

This figure shows the co-authorship network connecting the top 25 collaborators of Raimón Sanmartí. A scholar is included among the top collaborators of Raimón Sanmartí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raimón Sanmartí. Raimón Sanmartí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanmartí, Raimón, et al.. (2025). Nontraumatic terminal ileal perforation in a patient with resistant palindromic rheumatism treated with sarilumab: A case report. Reumatología Clínica (English Edition). 21(2). 501811–501811.
2.
3.
Sarmiento-Monroy, Juan Camilo, Andrés Ponce, José A. Gómez‐Puerta, et al.. (2024). Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice. Diagnostics. 14(15). 1637–1637.
4.
Novella-Navarro, Marta, Virginia Ruíz-Esquide, I. Monjo, et al.. (2024). Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical Rheumatology. 43(9). 2817–2823. 1 indexed citations
5.
Sanmartí, Raimón, et al.. (2023). Neutrófilos, trampas extracelulares de neutrófilos y artritis reumatoide: una revisión actualizada para clínicos. Reumatología Clínica. 19(9). 515–526. 8 indexed citations
6.
Augé, Josep M., Andrés Ponce, Juan Camilo Sarmiento-Monroy, et al.. (2023). Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers. 15(11). 2984–2984. 2 indexed citations
7.
Pérez‐Pampín, Eva, María J. Gómara, Juan Camilo Sarmiento-Monroy, et al.. (2023). Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression. Arthritis Research & Therapy. 25(1). 192–192.
8.
Ponce, Andrés, J. Inciarte-Mundo, Rosa Morlà, et al.. (2022). Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221114105–1759720X221114105. 5 indexed citations
9.
Ruíz-Esquide, Virginia, et al.. (2022). Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report. Rheumatology International. 43(3). 533–536. 1 indexed citations
10.
Julià, Antonio, María López‐Lasanta, Francisco J. Blanco, et al.. (2021). Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskeletal Disorders. 22(1). 372–372. 12 indexed citations
11.
Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2021). OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA. Annals of the Rheumatic Diseases. 80. 108–108.
12.
Castellanos‐Moreira, Raúl, S. C. Rodriguez-García, María J. Gómara, et al.. (2020). Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Annals of the Rheumatic Diseases. 79(5). 587–594. 54 indexed citations
13.
Gifre, Laia, Virginia Ruíz-Esquide, Antoni Xaubet, et al.. (2010). Sarcoidosis pulmonar inducida por antagonistas del factor de necrosis tumoral en la artritis reumatoide: presentación de un caso y revisión de la literatura médica. Archivos de Bronconeumología. 47(4). 208–212. 26 indexed citations
14.
Dijkmans, Ben A. C., Paul Emery, Markku Hakala, et al.. (2009). Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis. The Journal of Rheumatology. 36(6). 1256–1264. 51 indexed citations
15.
Cañete, Juan D., Juan I. Aróstegui, Rubén Queiró, et al.. (2007). An unexpectedly high frequency of MEFV mutations in patients with anti–citrullinated protein antibody–negative palindromic rheumatism. Arthritis & Rheumatism. 56(8). 2784–2788. 51 indexed citations
16.
Sanmartí, Raimón, Guadalupe Ercilla, M. Larrosa, et al.. (2006). Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids. Clinical Rheumatology. 26(7). 1111–1118. 41 indexed citations
17.
Rodríguez‐Valverde, Vicente, Rafael Cáliz, J. Mulero Mendoza, et al.. (2004). Segunda actualización del consenso de la Sociedad Española de Reumatología sobre la terapia biológica en la artritis reumatoide. 31(6). 394–401. 5 indexed citations
18.
Salvador, Georgina & Raimón Sanmartí. (2003). Reumatismo palindrÓmico: ¿entidad independiente o forma frustrada de artritis reumatoide?. 30(4). 172–176. 3 indexed citations
19.
Sanmartí, Raimón. (2000). Se puede predecir la evolución de la artritis reumatoide. 27(6). 260–265. 1 indexed citations
20.
Cañete, Juan D., J. F. Llena, Antonio Collado, et al.. (1997). Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies. Lara D. Veeken. 36(1). 38–42. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Le Loët Breakdown of academic impact, for papers by Juan D. Cañete Breakdown of academic impact, for papers by Mahboob U. Rahman Breakdown of academic impact, for papers by Mary Chester Wasko Breakdown of academic impact, for papers by Jon T. Giles Breakdown of academic impact, for papers by Alejandro Balsa Breakdown of academic impact, for papers by E. Martín‐Mola Breakdown of academic impact, for papers by FC Breedveld Breakdown of academic impact, for papers by Elisa Gremese Breakdown of academic impact, for papers by Thasia Woodworth
Rankless by CCL
2026